Trinity Biotech (TRIB) Accumulated Expenses (2016 - 2020)
Trinity Biotech (TRIB) has disclosed Accumulated Expenses for 5 consecutive years, with $8.8 million as the latest value for Q4 2020.
- Quarterly Accumulated Expenses rose 8.82% to $8.8 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Dec 2020, up 8.82% year-over-year, with the annual reading at $8.8 million for FY2020, 8.82% up from the prior year.
- Accumulated Expenses hit $8.8 million in Q4 2020 for Trinity Biotech, up from $8.1 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $11.6 million in Q4 2017 to a low of $7.9 million in Q4 2018.
- Historically, Accumulated Expenses has averaged $9.5 million across 5 years, with a median of $8.8 million in 2020.
- Biggest five-year swings in Accumulated Expenses: crashed 32.19% in 2018 and later increased 8.82% in 2020.
- Year by year, Accumulated Expenses stood at $10.9 million in 2016, then rose by 6.81% to $11.6 million in 2017, then plummeted by 32.19% to $7.9 million in 2018, then grew by 3.24% to $8.1 million in 2019, then grew by 8.82% to $8.8 million in 2020.
- Business Quant data shows Accumulated Expenses for TRIB at $8.8 million in Q4 2020, $8.1 million in Q4 2019, and $7.9 million in Q4 2018.